Xanthon Inc.
http://www.xanthon.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Xanthon Inc.
The Next Step in Clinical Genetic Testing
Start-ups are scrambling to develop methods for analyzing genetic information, but most of their efforts are directed at the research market. Only a handful of companies are seriously looking at improving the process in the clinical lab. Their biggest challenges: overcoming PCR's dominance and distinguishing themselves from competitors. The field can't really take off, however, until new applications of genetic tests show medical value.
Novalon Pharmaceutical
Ultra-high-throughput screening
Xanthon Inc.
Molecular Diagnostics. Xanthon claims it is developing a platform technology that will allow target squences of DNA or RNA to be detected with far less handling than PCR now requires. The technology takes advantage of the electrochemical properties of DNA. Xanthon attaches a membrane to an electrode and probes to the membrane. If a target sequence is present in the sample exposed to the membrane, it will bind, or hybridize there.
Company Information
- Industry
- Biotechnology
- Research, Analytical Equipment & Supplies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice